Tenshi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TENSHI, and what generic and branded alternatives to TENSHI drugs are available?
TENSHI has two approved drugs.
Summary for Tenshi
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Tenshi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tenshi | LORATADINE | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 212795-001 | Sep 18, 2020 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Tenshi | LORATADINE | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 213294-001 | Oct 30, 2020 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
